Antimicrobial Agents Practice Questions

Q: The drug of choice in mycoplasma pneumonia in children is –

Erythromycin. ***Erythromycin*** - **Erythromycin**, a macrolide antibiotic, is the drug of choice for treating **Mycoplasma pneumoniae** infections in children. - **Mycoplasma pneumoniae** lacks a cell wall, making antibiotics that target cell wall synthesis (like penicillins or cephalosporins) ineffective. Macrolides inhibit protein synthesis. *Tetracycline* - **Tetracyclines** are effective against **Mycoplasma pneumoniae**, but are generally avoided in children under 8 years due to the risk of permanent **tooth discoloration** and **bone growth inhibition**. - While effective, its side effect profile in pediatric patients makes it a less preferred first-line option. *Cotrimoxazole* - **Cotrimoxazole** (trimethoprim/sulfamethoxazole) is effective against various bacterial infections but is not the primary drug of choice for **Mycoplasma pneumoniae**. - Its mechanism of action involves inhibiting folate synthesis, which is not the principal target for **Mycoplasma** infections. *Streptomycin* - **Streptomycin** is an aminoglycoside antibiotic primarily used for treating **tuberculosis** and some severe gram-negative infections. - It is not effective against **Mycoplasma pneumoniae** and has significant side effects, including **ototoxicity** and **nephrotoxicity**.

Q: Which one of the following antibiotics inhibits transpeptidation in bacterial cell wall synthesis?

Penicillin. ***Penicillin*** - Penicillin is a **beta-lactam antibiotic** that targets bacterial cell wall synthesis by inhibiting the enzyme **transpeptidase** (penicillin-binding proteins). - This inhibition prevents the cross-linking of **peptidoglycan strands**, leading to a weakened cell wall and subsequent bacterial lysis. *Chloramphenicol* - **Chloramphenicol** inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**, thereby preventing peptide bond formation (peptidyl transferase activity). - It does not act on the bacterial cell wall. *Vancomycin* - **Vancomycin** is a **glycopeptide antibiotic** that inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala terminus** of peptidoglycan precursors. - It prevents the **transglycosylation and transpeptidation steps** by blocking substrate access, but it does not directly inhibit the transpeptidase enzyme itself like beta-lactams do. - Its mechanism is distinct from penicillin's direct enzyme inhibition. *Amphotericin* - **Amphotericin B** is an **antifungal agent** that targets the fungal cell membrane by binding to **ergosterol**, forming pores that disrupt membrane integrity. - It has no activity against bacterial cell wall synthesis.

Q: Continued suppression of bacterial growth after antibiotic levels have fallen below the Minimum Inhibitory Concentration (MIC) is known as?

Post antibiotic effect. ***Post antibiotic effect*** - The **post-antibiotic effect (PAE)** refers to the continued suppression of bacterial growth after antibiotic levels have fallen below the **Minimum Inhibitory Concentration (MIC)**. - This phenomenon allows for less frequent dosing while maintaining efficacy, which is important for drug scheduling. *Time dependent killing* - **Time-dependent killing** means that the duration for which the antibiotic concentration stays above the **MIC** is the most important factor for efficacy, not necessarily the peak concentration. - Antibiotics with this characteristic, such as **beta-lactams**, often require frequent dosing or continuous infusion. *Sequential blockade* - **Sequential blockade** occurs when two drugs act on consecutive steps in a metabolic pathway, leading to a synergistic effect that results in enhanced microbial killing. - A classic example is the combination of **sulfamethoxazole and trimethoprim**, which inhibit different enzymes in the folic acid synthesis pathway. *Concentration dependent killing* - **Concentration-dependent killing** indicates that the rate and extent of bacterial killing increase as the antibiotic concentration rises, particularly when it exceeds the **MIC**. - Antibiotics like **aminoglycosides** exhibit this effect, often benefiting from high peak concentrations to maximize efficacy.

Q: Which of the following statements about terbinafine is FALSE?

Its activity is restricted to dermatophytes. Its activity is restricted to dermatophytes - This statement is **false** because while **terbinafine** is highly effective against **dermatophytes**, it also exhibits activity against other fungi like *Candida* species and *Aspergillus*, especially at higher concentrations. - Its broad-spectrum fungicidal action differentiates it from azoles, which are primarily fungistatic and target a wider range of fungi. *It is effective in onychomycosis* - **Terbinafine** is a **first-line treatment** for **onychomycosis** due to its high efficacy, ability to penetrate nail tissue, and fungicidal action against dermatophytes [1]. - It accumulates in the nail plate, providing sustained antifungal effects, leading to high cure rates in fungal nail infections. *It is unlikely to produce anti-androgenic side effects* - **Terbinafine** acts by inhibiting **squalene epoxidase** in the fungal cell membrane, which is distinct from the **cytochrome P450 enzymes** involved in **steroid hormone synthesis**. - Therefore, it does not interfere with human androgen receptors or steroid synthesis pathways, making **anti-androgenic side effects** highly unlikely, unlike some azole antifungals. *It is not effective in cryptococcal meningitis* - **Terbinafine** primarily concentrates in **skin, nails, and adipose tissue**, and its **penetration into the central nervous system (CNS)** is poor. - **Cryptococcal meningitis** requires antifungal agents that can effectively cross the blood-brain barrier, such as **amphotericin B** and **flucytosine**, which terbinafine cannot achieve [1].

Q: Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT

Quinolone. ***Quinolone*** - The primary mechanisms of resistance to **quinolones** involve mutations in the **gyrase** and **topoisomerase IV** enzymes or efflux pump overexpression, rather than enzymatic inactivation of the drug itself. - Unlike other antibiotic classes listed, quinolones are not typically susceptible to bacterial enzymes that degrade or modify their structure. *Penicillin* - **Penicillins** are highly susceptible to inactivation by **beta-lactamase enzymes**, which hydrolyze the beta-lactam ring, rendering the antibiotic ineffective. - This enzymatic degradation is a major mechanism of resistance developed by many bacterial species to penicillin and other beta-lactam antibiotics. *Chloramphenicol* - Resistance to **chloramphenicol** is primarily mediated by the enzyme **chloramphenicol acetyltransferase (CAT)**, which acetylates the drug, preventing its binding to the bacterial ribosome. - This enzymatic modification is a classic example of drug inactivation leading to resistance. *Aminoglycoside* - **Aminoglycosides** are frequently inactivated by a variety of **aminoglycoside-modifying enzymes (AMEs)**, such as acetyltransferases, phosphoryltransferases, and nucleotidyltransferases. - These enzymes add chemical moieties to the aminoglycoside molecule, preventing its binding to the bacterial ribosome and inhibiting protein synthesis.

Q: β-lactamases cause resistance to penicillins and cephalosporins by

Breaking one chemical bond. ***Breaking one chemical bond*** - β-lactamases mediate resistance by **hydrolyzing a single amide bond** within the **β-lactam ring** of penicillins and cephalosporins [1]. - This hydrolysis opens the β-lactam ring, rendering the antibiotic **inactive** and unable to bind to **penicillin-binding proteins (PBPs)** [1, 2].*Inhibiting transpeptidase enzymes* - This describes the **mechanism of action of β-lactam antibiotics themselves**, not the mechanism of resistance by β-lactamases. - β-lactam antibiotics work by **irreversibly binding to and inhibiting transpeptidase enzymes** (PBPs), which are crucial for bacterial cell wall synthesis.*Adding amino (NH2) groups to a molecule* - This mechanism, known as **acetylation or adenylation**, is characteristic of resistance to certain other antibiotic classes, such as **aminoglycosides**. - It does not describe how β-lactamases confer resistance to β-lactam antibiotics.*Breaking two chemical bonds* - While β-lactamase action involves breaking a bond, it specifically involves the **hydrolysis of a single amide bond** in the β-lactam ring. - Breaking two distinct chemical bonds is not the mechanism by which β-lactamases inactivate these antibiotics.

Q: Chemoprophylaxis of malaria can be done by all except:

Primaquine. ***Primaquine*** - Primaquine is primarily used for **radical cure** of *P. vivax* and *P. ovale* malaria by targeting **hypnozoites** in the liver, and for **terminal prophylaxis (PART)** after exposure ends. - While it can be used for primary prophylaxis in special circumstances, it is **not a first-line choice** for routine traveler chemoprophylaxis due to its short half-life requiring daily dosing, and the risk of **hemolysis in G6PD-deficient individuals**. - Unlike other options listed, primaquine is not routinely recommended as a standard prophylactic agent. *Chloroquine* - Chloroquine remains an effective prophylactic agent for malaria in areas with **chloroquine-sensitive strains**. - Its use has become limited due to widespread **chloroquine resistance**, especially to *P. falciparum*, but it is still used for prophylaxis in sensitive regions. *Proguanil* - Proguanil is commonly used in combination with **atovaquone** (as Malarone) or **chloroquine** for malaria prophylaxis in many regions. - It acts by inhibiting **dihydrofolate reductase**, disrupting parasite DNA synthesis and replication. *Mefloquine* - Mefloquine is an effective prophylactic agent for areas with **multi-drug resistant *P. falciparum***. - It is typically taken once weekly, but its use can be limited by potential **neuropsychiatric side effects**.

Q: Drug of choice for carriers of typhoid is

Ciprofloxacin. ***Ciprofloxacin*** - **Ciprofloxacin** is the **drug of choice** for treating **chronic carriers** of **typhoid fever** due to its good penetration into tissues where Salmonella typhi can persist, such as the gallbladder. - It is a **fluoroquinolone**, effective against intracellular bacteria and achieves high concentrations in bile. *Chloramphenicol* - While effective for **acute typhoid fever**, **Chloramphenicol** is generally **not recommended** for treating **carriers** due to its potential for serious side effects, such as **bone marrow suppression** (aplastic anemia). - Its use has largely been replaced by safer and equally effective alternatives for carrier states. *Co-trimoxazole* - **Co-trimoxazole** (trimethoprim-sulfamethoxazole) can be used for **acute typhoid**, but it is **less effective** than fluoroquinolones for eradicating the **carrier state**. - Resistance to co-trimoxazole is also increasing, further limiting its utility for chronic carriers. *Clindamycin* - **Clindamycin** is primarily effective against **anaerobic bacteria** and some gram-positive cocci; it has **no significant activity** against **Salmonella typhi**. - Therefore, it is **not used** in the treatment of typhoid fever or its carrier state.

Question 1

The drug of choice in mycoplasma pneumonia in children is –

Accepted Answer

Erythromycin

Answer

Tetracycline

Answer

Cotrimoxazole

Answer

Streptomycin

Question 2

Which one of the following antibiotics inhibits transpeptidation in bacterial cell wall synthesis?

Accepted Answer

Penicillin

Answer

Chloramphenicol

Answer

Amphotericin

Answer

Vancomycin

Question 3

Continued suppression of bacterial growth after antibiotic levels have fallen below the Minimum Inhibitory Concentration (MIC) is known as?

Accepted Answer

Post antibiotic effect

Answer

Time dependent killing

Answer

Sequential blockade

Answer

Concentration dependent killing

Question 4

Which of the following statements about terbinafine is FALSE?

Accepted Answer

Its activity is restricted to dermatophytes

Answer

It is effective in onychomycosis

Answer

It is unlikely to produce anti-androgenic side effects

Answer

It is not effective in cryptococcal meningitis

Question 5

Which of the following statements regarding drugs used in leprosy is false

Accepted Answer

Clofazimine should not be given to patients who are intolerant to dapsone or who fail to improve during treatment with dapsone

Answer

Clofazimine may cause changes in skin colour

Answer

Single intramuscular injections of acedapsone maintain inhibitory levels of dapsone in tissues for up to 3 months

Answer

Monthly doses of rifampicin delay the emergence of resistance to dapsone

Question 6

Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT

Accepted Answer

Quinolone

Answer

Penicillin

Answer

Chloramphenicol

Answer

Aminoglycoside

Question 7

β-lactamases cause resistance to penicillins and cephalosporins by

Accepted Answer

Breaking one chemical bond

Answer

Inhibiting transpeptidase enzymes

Answer

Adding amino (NH2) groups to a molecule

Answer

Breaking two chemical bonds

Question 8

Chemoprophylaxis of malaria can be done by all except:

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Proguanil

Answer

Mefloquine

Question 9

Drug of choice for carriers of typhoid is

Accepted Answer

Ciprofloxacin

Answer

Chloramphenicol

Answer

Co-trimoxazole

Answer

Clindamycin

Question 10

The following statements are true about DPT vaccine except

Accepted Answer

Presence of acellular pertussis component increases its immunogenicity

Answer

Whole killed bacteria of Bordetella pertussis has an adjuvant effect

Answer

Aluminium salt has an adjuvant effect

Answer

Presence of Hemophilus influenza type B component increases the immunogenicity of pertussis component

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?